Investigation of the Relationship Between DNA Mismatch Repair Genes and Microsatellite Instability in Solid Tumors

Ozkan Bagci

Makale detayları

Investigation of the Relationship Between DNA Mismatch Repair Genes and Microsatellite Instability in Solid Tumors

Yazarlar:

Ozkan Bagci

Yayıncı:

Selcuk University

Ana Başlıklar:

Tıbbi Genetik (Kanser Genetiği hariç)

Dergi:

Genel Tıp Dergisi Vol.34 Issue 5, pp.689-695

Belge Tipi:

Makale

Yayın Tarihi:

10/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001330476

pISSN:

2602-3741

Anahtar kelimeler:

Özet:

 Aim: In this study, we aimed to detect the MSI status and somatic mutations in MMR genes MSH2, MSH6, MLH1, PMS2 of a total of 55 solid tumors diagnosed with colorectal, endometrium and ovarian cancer by NGS method and to reveal the relationship between them. Material and Method: DNA isolation was performed by taking 10-micron sections from paraffin-embedded tissue samples of 55 patients diagnosed with kolorektal, endometrium ve ovarian solid tümörlerinin and Kapa NGS DNA extraction kit was used for sequence analysis. The purity and concentration of the DNA obtained was measured by Qubit fluoremeter, and NadPrep DNA Universal Library Preparation Kit was used for high quality library preparation. Bioinformatics analyses were performed on the Genomize Seq platform. The MSI value was analysed by Roche Navify Mutation Caller software and percentage MSI values were determined using the MSIsensor2 pipeline for secondary analysis of NGS. Results: All ovarian tumors were in the MSI-Stable category. The average MSI value was 2.01. One sample had an MSI of zero. In addition, no mutations in the MSH2 and MLH1 genes were detected in any of the ovarian tumors. 3 of 4 endometrial tumors were in the MSI-Stable category, and 1 tumor was in the MSI-low MSI value: 13.2 category. No variants were detected in the MSH2 and PMS2 genes in endometrial tumors. 2 of the 41 colorectal tumors Case4, Case16 were in the MSI-High category. No variants were detected in the MMR genes in 19 tumors. Conclusion: Although frame-shift and stop-gain mutations were detected in 23 tumors that would cause protein deficiency in MMR genes, MSI-H was not detected, as expected, except for two colorectal tumors. Therefore, the results of our study emphasise the need to define new predictive biomarkers clinically within the framework of algorithms to predict response to immunotherapy and determine prognosis.

 Aim: In this study, we aimed to detect the MSI status and somatic mutations in MMR genes MSH2, MSH6, MLH1, PMS2 of a total of 55 solid tumors diagnosed with colorectal, endometrium and ovarian cancer by NGS method and to reveal the relationship between them. Material and Method: DNA isolation was performed by taking 10-micron sections from paraffin-embedded tissue samples of 55 patients diagnosed with kolorektal, endometrium ve ovarian solid tümörlerinin and Kapa NGS DNA extraction kit was used for sequence analysis. The purity and concentration of the DNA obtained was measured by Qubit fluoremeter, and NadPrep DNA Universal Library Preparation Kit was used for high quality library preparation. Bioinformatics analyses were performed on the Genomize Seq platform. The MSI value was analysed by Roche Navify Mutation Caller software and percentage MSI values were determined using the MSIsensor2 pipeline for secondary analysis of NGS. Results: All ovarian tumors were in the MSI-Stable category. The average MSI value was 2.01. One sample had an MSI of zero. In addition, no mutations in the MSH2 and MLH1 genes were detected in any of the ovarian tumors. 3 of 4 endometrial tumors were in the MSI-Stable category, and 1 tumor was in the MSI-low MSI value: 13.2 category. No variants were detected in the MSH2 and PMS2 genes in endometrial tumors. 2 of the 41 colorectal tumors Case4, Case16 were in the MSI-High category. No variants were detected in the MMR genes in 19 tumors. Conclusion: Although frame-shift and stop-gain mutations were detected in 23 tumors that would cause protein deficiency in MMR genes, MSI-H was not detected, as expected, except for two colorectal tumors. Therefore, the results of our study emphasise the need to define new predictive biomarkers clinically within the framework of algorithms to predict response to immunotherapy and determine prognosis.

 Aim: In this study, we aimed to detect the MSI status and somatic mutations in MMR genes MSH2, MSH6, MLH1, PMS2 of a total of 55 solid tumors diagnosed with colorectal, endometrium and ovarian cancer by NGS method and to reveal the relationship between them. Material and Method: DNA isolation was performed by taking 10-micron sections from paraffin-embedded tissue samples of 55 patients diagnosed with kolorektal, endometrium ve ovarian solid tümörlerinin and Kapa NGS DNA extraction kit was used for sequence analysis. The purity and concentration of the DNA obtained was measured by Qubit fluoremeter, and NadPrep DNA Universal Library Preparation Kit was used for high quality library preparation. Bioinformatics analyses were performed on the Genomize Seq platform. The MSI value was analysed by Roche Navify Mutation Caller software and percentage MSI values were determined using the MSIsensor2 pipeline for secondary analysis of NGS. Results: All ovarian tumors were in the MSI-Stable category. The average MSI value was 2.01. One sample had an MSI of zero. In addition, no mutations in the MSH2 and MLH1 genes were detected in any of the ovarian tumors. 3 of 4 endometrial tumors were in the MSI-Stable category, and 1 tumor was in the MSI-low MSI value: 13.2 category. No variants were detected in the MSH2 and PMS2 genes in endometrial tumors. 2 of the 41 colorectal tumors Case4, Case16 were in the MSI-High category. No variants were detected in the MMR genes in 19 tumors. Conclusion: Although frame-shift and stop-gain mutations were detected in 23 tumors that would cause protein deficiency in MMR genes, MSI-H was not detected, as expected, except for two colorectal tumors. Therefore, the results of our study emphasise the need to define new predictive biomarkers clinically within the framework of algorithms to predict response to immunotherapy and determine prognosis.

 Amaç: Bu çalışmada kolorektal, endometrium ve over kanseri tanısı almış toplam 55 solid tümörün MSI durumunu ve MMR genlerindeki MSH2, MSH6, MLH1, PMS2 somatik mutasyonları NGS yöntemi ile tespit etmeyi ve aralarındaki ilişkiyi ortaya koymayı amaçladık. Gereç ve Yöntem: Kolorektal, endometrium ve yumurtalık kanseri tanısı almış 55 solid tümör örneklerinden 10 mikronluk kesitler alınarak DNA izolasyonu gerçekleştirilmiş ve dizi analizi için Kapa NGS DNA ekstraksiyon kiti kullanılmıştır. Elde edilen DNAnın saflığı ve konsantrasyonu Qubit floremetre ile ölçülmüş, yüksek kalitede kütüphane hazırlanması için NadPrep DNA Universal Library Preparation Kit kullanılmıştır. Biyoinformatik analizler Genomize Seq platformunda gerçekleştirilmiştir. MSI değeri Roche Navify Mutation Caller yazılımı ile analiz edilmiş ve yüzde MSI değerleri NGSnin ikincil analizi için MSIsensor2 boru hattı kullanılarak belirlenmiştir. Bulgular: Tüm yumurtalık tümörleri MSI-Stabil kategorisindeydi. Ortalama MSI değeri 2,01 idi. Bir örneğin MSI değeri sıfırdı. Ayrıca, yumurtalık tümörlerinin hiçbirinde MSH2 ve MLH1 genlerinde mutasyon tespit edilmemiştir. 4 endometriyal tümörün 3ü MSI-Stabil kategorisinde ve 1 tümör MSI-düşük MSI değeri: 13,2 kategorisindeydi. Endometriyal tümörlerde MSH2 ve PMS2 genlerinde herhangi bir varyant tespit edilmemiştir. 41 kolorektal tümörün 2si Vaka4, Vaka16 MSI-Yüksek kategorisindeydi. MMR genlerinde 19 tümörde herhangi bir varyant tespit edilmemiştir. Sonuç: MMR genlerinde protein eksikliğine neden olabilecek çerçeve kayması ve stop-gain mutasyonları 23 tümörde tespit edilmesine rağmen, iki kolorektal tümör dışında beklendiği gibi MSI-H tespit edilmemiştir. Bu nedenle, çalışmamızın sonuçları, immünoterapiye yanıtı öngörmek ve prognozu belirlemek için algoritmalar çerçevesinde klinik olarak yeni öngörücü biyobelirteçlerin tanımlanması gerektiğini vurgulamaktadır.

Makale detayları

Investigation of the Relationship Between DNA Mismatch Repair Genes and Microsatellite Instability in Solid Tumors

Yazarlar:

Ozkan Bagci

Yayıncı:

Selcuk University

Ana Başlıklar:

Tıbbi Genetik (Kanser Genetiği hariç)

Dergi:

Genel Tıp Dergisi Vol.34 Issue 5, pp.689-695

Belge Tipi:

Makale

Yayın Tarihi:

10/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001330476

pISSN:

2602-3741

Colorectal cancer

Endometrium cancer

Ovarian cancer

MMR

MSIKolorektal kanser

Endometrium kanseri

Yumurtalık kanseri

MMR

MSI

Sayı

Makale detayları

Yazarlar: Ozkan Bagci

Yayıncı: Selcuk University

Ana Başlıklar: Tıbbi Genetik (Kanser Genetiği hariç)

Dergi: Genel Tıp Dergisi Vol.34 Issue 5, pp.689-695

Belge Tipi: Makale

Yayın Tarihi: 10/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001330476

pISSN: 2602-3741

Sayı

Yazarlar:

Ozkan Bagci

Yayıncı:

Selcuk University

Ana Başlıklar:

Tıbbi Genetik (Kanser Genetiği hariç)

Dergi:

Genel Tıp Dergisi Vol.34 Issue 5, pp.689-695

Belge Tipi:

Makale

Yayın Tarihi:

10/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001330476

pISSN:

2602-3741